Answers are grounded in this paper and cite their sources.
Objective To characterize early perioperative outcomes after esophagectomy for esophageal or gastroesophageal junction cancer and explore whether the association between red-blood-cell transfusion and major morbidity varies by transfusion timing. Material and Methods Consecutive resections performed between September 2018 and January 2026 were reviewed retrospectively. Sixty-one of 66 screened patients were included. Major morbidity was defined as Clavien-Dindo grade IIIa or higher. Transfusion was categorized as none, intraoperative only, postoperative only, or both. Sparse categorical comparisons used exact tests. Results Neoadjuvant treatment was administered to 56 patients (91.8%). R0 resection was achieved in 57 (93.4%); median lymph node yield was 13 (interquartile range 10-18). Major morbidity occurred in 26 patients (42.6%), anastomotic leak in 11 (18.0%), pneumonia in 20 (32.8%), and 90-day mortality in 6 (9.8%). Major morbidity occurred in 22.9% without transfusion, 33.3% with intraoperative-only transfusion, 72.7% with postoperative-only transfusion, and 88.9% with both (global exact p<0.001). Intraoperative-only transfusion was not associated with major morbidity versus no transfusion [odds ratio (OR) 1.69, 95% confidence interval (CI) 0.26-10.97; p=0.622], whereas postoperative-only transfusion was associated with major morbidity (OR 9.00, 95% CI 1.92-42.14; p=0.004). Conclusion Margin-negative resection was comparable with international benchmarks, whereas perioperative morbidity remained substantial. The transfusion signal was concentrated after surgery and should be interpreted as a marker of a complicated perioperative course rather than evidence of a causal transfusion effect.
No takes yet. Share an insight, caveat, or question.
Sarıdemir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: